Loratadine Tablet
Product Images NDC 58602-831

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loratadine (NDC 58602-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (10 mg (45 Tablets Bottle))

Package Label-principal Display Panel (10 mg (45 Tablets Bottle))
This is a description for Loratadine Tablets USP 10 mg, which is a non-drowsy antihistamine medication for indoor and outdoor allergies. The text also includes a product code and information about the lot and expiration dates. The remaining text appears to be a random assortment of characters and numbers, and is not relevant or understandable.*
FDA Label Image

Fig2 (Loratadine Fig2)

Fig2 (Loratadine Fig2)
This is a description of a medication called Loratadine. The medication is meant to relieve allergy symptoms such as sneezing, runny nose, and itchy or watery eyes. It comes in the form of tablets, and the dosage is 10 mg per tablet. The medication is distributed by Aurohealth LLC and is a non-drowsy antihistamine. The package contains 45 tablets, and the drug facts and directions for use can be found on the packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.